TrialCancer medicine2020

VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).

Jaime Feliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.